Sandesh Mahatme Net Worth & Insider Trades
Sandesh Mahatme - EVP, Sarepta Therapeutics, Inc
What is Sandesh Mahatme's Net Worth?
The current estimated net worth of Sarepta Therapeutics, Inc's EVP, Sandesh Mahatme, is estimated to be about $56.21M . Sandesh Mahatme owns about 42,191 units of Sarepta Therapeutics, Inc common stock. In the last 8 years at Sarepta Therapeutics, Inc, Sandesh Mahatme has sold an estimated value of $58.92M worth.
What is Sandesh Mahatme's Past Insider Trading?
Sandesh Mahatme's largest purchase order was 125,000 units , worth over $3.61M on December 17, 2019. Sandesh Mahatme's largest sale order was 125,000 units , worth over $15.69M on December 17, 2019. In total, Sandesh Mahatme has made about 29 transactions over 8 years of their time at Sarepta Therapeutics, Inc. Sandesh Mahatme usually trades in March, with the busiest year in 2019.
Sandesh Mahatme
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Sandesh Mahatme's Salary in 2020?
As EVP of Sarepta Therapeutics, Inc, Sandesh Mahatme has a total base salary of $312,835 . Sandesh Mahatme received compensation valued at about $3,364,021 in 2020 after becoming EVP. The vast majority of their compensation came in the form of stock awards of $766,949 , other earnings, plans or compensations of $39,413 , other earnings, plans or compensations of $39,413 , and other earnings, plans or compensations of $39,413 .
What is Sandesh Mahatme's' Mailing Address?
- Mailing address is C/o Celgene Corporation 86 Morris Avenue Summit NJ 07901 NJ
Sarepta Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|---|
| Douglas S. Ingram | 2020 | $669,250 | - | $17,222 | $17,222 | $17,222 | $1,291,947 |
| Douglas S. Ingram | 2019 | $650,000 | - | $5,822 | $5,822 | $5,822 | $1,387,072 |
| Douglas S. Ingram | 2018 | $650,000 | - | $5,822 | $5,822 | $5,822 | $1,433,872 |
| Ian M. Estepan | 2020 | $445,822 | $434,986 | $32,744 | $32,744 | $32,744 | $5,177,681 |
| Ian M. Estepan | 2019 | - | - | - | - | - | - |
| Ian M. Estepan | 2018 | - | - | - | - | - | - |
| Gilmore O'Neill, M.B., M.M.Sc. | 2020 | $583,277 | $766,949 | $15,500 | $15,500 | $15,500 | $3,790,049 |
| Gilmore O'Neill, M.B., M.M.Sc. | 2019 | $563,962 | - | $15,300 | $15,300 | $15,300 | $5,168,110 |
| Gilmore O'Neill, M.B., M.M.Sc. | 2018 | $310,962 | $1,154,760 | $2,050 | $2,050 | $2,050 | $6,449,176 |
| William Ciambrone | 2020 | $458,179 | - | $14,500 | $14,500 | $14,500 | $679,938 |
| William Ciambrone | 2019 | $51,346 | - | $1,000 | $1,000 | $1,000 | $4,345,194 |
| William Ciambrone | 2018 | - | - | - | - | - | - |
| Louise Rodino-Klapac, Ph.D. | 2020 | $495,590 | $766,949 | $13,532 | $13,532 | $13,532 | $7,269,509 |
| Louise Rodino-Klapac, Ph.D. | 2019 | - | - | - | - | - | - |
| Louise Rodino-Klapac, Ph.D. | 2018 | - | - | - | - | - | - |
| Joseph Bratica | 2020 | $326,028 | $237,525 | $11,645 | $11,645 | $11,645 | $911,887 |
| Joseph Bratica | 2019 | - | - | - | - | - | - |
| Joseph Bratica | 2018 | - | - | - | - | - | - |
| Sandesh Mahatme | 2020 | $312,835 | $766,949 | $39,413 | $39,413 | $39,413 | $3,364,021 |
| Sandesh Mahatme | 2019 | $557,327 | - | $14,840 | $14,840 | $14,840 | $5,161,209 |
| Sandesh Mahatme | 2018 | $498,112 | - | $24,838 | $24,838 | $24,838 | $4,219,084 |
| David Tyronne Howton, Jr. | 2020 | $470,695 | $1,050,929 | $157,280 | $157,280 | $157,280 | $5,703,078 |
| David Tyronne Howton, Jr. | 2019 | $458,844 | - | $13,318 | $13,318 | $13,318 | $4,196,622 |
| David Tyronne Howton, Jr. | 2018 | $438,185 | - | $13,118 | $13,118 | $13,118 | $3,129,375 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/873303/000156459021019631/srpt-def14a_20210603.htm
What are Sarepta Therapeutics, Inc's Past Insider Trades?
Sarepta Therapeutics, Inc's most recent insider trade came on November 21, 2022 by Stephen Mayo who sold 858 units worth $94.31K . In the last 10 years, insiders at Sarepta Therapeutics, Inc have sold an estimated value of $177.49M and bought an estimated value of $53.33M worth of shares. Insider trading is most common in March, with the busiest year in 2017. The most active traders at the company are Sandesh Mahatme, EVP, David T Howton, EVP, and Edward M. Kaye, Director .
Sarepta Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||